Anti-inflammatory effects of levosimendan in decompensated heart failure: impact on weight loss and anemia

Am J Cardiol. 2005 Apr 1;95(7):923-4. doi: 10.1016/j.amjcard.2004.11.018.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anemia / drug therapy*
  • Anti-Inflammatory Agents / therapeutic use*
  • Cardiotonic Agents / therapeutic use
  • Heart Failure / drug therapy*
  • Humans
  • Hydrazones / therapeutic use*
  • Pyridazines / therapeutic use*
  • Simendan
  • Weight Loss / drug effects*

Substances

  • Anti-Inflammatory Agents
  • Cardiotonic Agents
  • Hydrazones
  • Pyridazines
  • Simendan